Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Medical Oncology (Northwood, London, England)|December 27, 2025
A therapeutic approach of LC-MS characterised MFER-Mc against alcohol and NDEA induced hepatocellular carcinoma activity through LXR-α, LXR-β and HMG-CoA pathway: an in-silico, in-vitro and in-vivo studyShashi Ranjan, Priyashree Sunita, Shakti P Pattanayak
Current Cancer Drug Targets|October 15, 2025
Zinc-Facilitated Enzyme Disruption: Thiazolidinediones as Potent Carbonic Anhydrase Inhibitors in Hypoxic Cancer MicroenvironmentsGaurav Ranjan, Shakti Prasad Pattanayak, Priyashree Sunita
Recent Patents on Anti-Cancer Drug Discovery|May 21, 2026
CAIX-HIF-1α Inhibition by 2-(4-Chlorophenyl)-3-(4-Ethoxyphenyl) Thiazolidin-4-one (BCS12) Activates Caspase Cascade and PARP Cleavage, Driving Mitochondrial Apoptosis in Hypoxic Breast CancerGaurav Ranjan, Shakti Prasad Pattanayak, Priyashree Sunita
Current Microbiology|September 22, 2021
Molecular Insights into the Crosstalk Between Immune Inflammation Nexus and SARS-CoV-2 VirusPritha Bose, Priyashree Sunita, Shakti P Pattanayak
Clinical and Experimental Pharmacology & Physiology|June 15, 2016
Daphnetin inhibits TNF-α and VEGF-induced angiogenesis through inhibition of the IKKs/IκBα/NF-κB, Src/FAK/ERK1/2 and Akt signalling pathwaysAbhishek Kumar, Priyashree Sunita, Shivesh Jha, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 2, 2024
Thiazolidinedione derivatives in cancer therapy: exploring novel mechanisms, therapeutic potentials, and future horizons in oncologyGaurav Ranjan, Shashi Ranjan, Priyashree Sunita, et al.
Archives of Pharmacal Research|August 15, 2021
Molecular epigenetic dynamics in breast carcinogenesisAadrita Hazra, Pritha Bose, Priyashree Sunita, et al.
Journal of Physiology and Biochemistry|February 14, 2018
7,8-Dihydroxycoumarin exerts antitumor potential on DMBA-induced mammary carcinogenesis by inhibiting ERα, PR, EGFR, and IGF1R: involvement of MAPK1/2-JNK1/2-Akt pathwayAbhishek Kumar, Priyashree Sunita, Shivesh Jha, et al.
Cancer Treatment and Research|May 17, 2026
Metabolic Reprogramming in Cancer Stem CellsGaurav Ranjan, Srijani Dasgupta, Uttam Kumar Mishra, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 19, 2018
Bergapten inhibits liver carcinogenesis by modulating LXR/PI3K/Akt and IDOL/LDLR pathwaysShakti Prasad Pattanayak, Pritha Bose, Priyashree Sunita, et al.
Pageof 2